12:37 PM EDT, 08/22/2025 (MT Newswires) -- Invivyd ( IVVD ) said Friday it raised $57.5 million in gross proceeds through an underwritten public offering of about 89.2 million shares and 21.3 million pre-funded warrants, with underwriters fully exercising their option to purchase an additional 14.4 million common shares.

The company's common stock was priced at $0.52 per share and pre-funded warrants at $0.5199 each.

Net proceeds will be used to advance the VYD2311 clinical program, support research on pipeline candidates such as RSV and measles, fund the SPEAR Study Group's work on Long COVID and post-vaccination syndromes, and cover general corporate purposes.

Shares of Invivyd ( IVVD ) were down 3.1% in recent trading.

Price: 0.51, Change: -0.02, Percent Change: -3.11